Sanofi defends Garijo appointment and reaffirms commitment to immunology ahead of new CEO
read at Endpoints ↗EarningsNeutral
Sanofi held its first-quarter earnings call, with CFO François-Xavier Roger fielding questions from the media.
During the call he defended the recent appointment of Belén Garijo, formerly of Merck KGaA, stressing that the company remains fully committed to its immunology portfolio.
The remarks were made as Sanofi prepares for a new chief executive to assume the role next week, aiming to keep the strategic focus on growth and innovation.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “Sanofi defends Garijo appointment, says it is 'fully committed' to immunology”
read at Endpoints ↗85 words · retrieved Apr 26
comments(0)
5-min edit window · permanent after that